Navigation Links
Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
Date:3/29/2011

specialty pharmaceutical companies. We have built strong relationships with both equity and debt investors, who continue to support Valeant's growth plan.  We firmly believe that Valeant is a unique partner, which allows us to value Cephalon at a higher level than would other companies.      

Financial Terms

Valeant is pleased to propose the acquisition of 100% of the issued fully diluted common shares of the Company for $73.00 per share in cash.

The offer represents a premium of 33% to the closing price of the Company's common shares on March 17, 2011 and higher than Cephalon's shares have traded in over two years.  This represents a significant premium to the current share price and substantially all of the equity research analysts' target prices that have been updated to reflect recent developments.  We believe our offer price is compelling in light of ongoing challenges facing Cephalon and the general challenges facing the broader pharmaceutical industry, and we are convinced that your shareholders would find it extremely attractive.  

Transaction Process and Timing

Valeant has completed a detailed review of publicly available information relating to the Company.  We believe our additional confirmatory due diligence requirements could be completed quickly, likely in less than a month.  While we believe our offer fully values Cephalon, including the cost of your convertible securities and call spread overlay, we would consider revising our price higher if we find additional value in due diligence.  We look forward to discussing your business with you in more detail.  

Consummation of a transaction would require negotiation and execution of a definitive merger agreement, as well as other customary agreements for a transaction of this nature.  We are prepared to provide draft agreements promptly and anticipate that definitive agreements can be negoti
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Valeant to Acquire Polish Products
2. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
3. Valeant and Biovail Announce Results of Special Meetings of Shareholders
4. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
6. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
7. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
8. Valeant Announces Pricing of Senior Notes
9. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
10. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
11. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015 Jazz Pharmaceuticals plc (Nasdaq: ... webcasting its corporate presentation at the Cantor Fitzgerald Healthcare Conference ... Russell Cox , executive vice president ... company and a business and financial update on Wednesday, July ... A live audio webcast of the presentation ...
(Date:7/1/2015)... Lilly and Company (NYSE: LLY ) will announce its ... July 23, 2015. Lilly will also conduct a conference call ... further detail the company,s financial performance. The conference ... the general public can access a live webcast of the ... Lilly,s website at www.lilly.com . A replay will also ...
(Date:7/1/2015)... , July 1, 2015  goBalto, Inc., ... solutions, announced today unprecedented growth in serving pharmaceutical, ... intense pressure to speed clinical trials and restrain ... and paper-based methods have stalled these efforts," said ... status of clinical trials has encouraged Industry leaders, ...
Breaking Medicine Technology:Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 2Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement 2goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position 2
... HARLEYSVILLE, Pa. and LUDWIGSHAFEN, Germany, Oct. 20, 2011 ... the development of future film coating systems using Kollicoat® ... Colorcon has developed a pre-formulated additive ... enables efficient preparation and application of this polymer in ...
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... management to discuss third quarter 2011 financial results, as well ... 2011, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). ... will be released earlier that day. Interested parties ...
Cached Medicine Technology:Colorcon and BASF Announce Collaboration to Develop Film Coating Applications Using Kollicoat® Smartseal 30 D 2
(Date:7/2/2015)... ... July 02, 2015 , ... ... their products, services, channels and business models. To help manage the increasing demand ... addition of Mark Benkendorf as SVP of Strategic Engagements. , Benkendorf is a ...
(Date:7/1/2015)... ... 2015 , ... In the United States, summer has always been the season ... Arabia and Dubai, the summer temperatures are so hot, that July vacationers often leave ... Saleh of ORA Dentistry Spa notes that a trip to the United States, and ...
(Date:7/1/2015)... ... July 01, 2015 , ... Dr. ... Georgia State University and a Georgia Research Alliance Eminent Scholar in Inflammation and ... therapeutics against middle-ear infections. , The grant from the National Institute on Deafness ...
(Date:7/1/2015)... ... July 01, 2015 , ... The federal court overseeing a ... has granted the Defendants’ Motion for Summary Judgment. According to an Order issued ... the Court rejected the Plaintiff’s assertion that one manufacturer can be held ...
(Date:7/1/2015)... ... July 01, 2015 , ... There ... liberty. Americans have been arguing over laws governing sexuality since the first Pilgrims ... a forthcoming historical comparative biography by Cindy Safronoff reveals. Crossing Swords: Mary Baker ...
Breaking Medicine News(10 mins):Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4
... , , DALLAS, Sept. 11 ... (OTC Bulletin Board: ACCP) has entered into an agreement with ... distribution. One or more U.S. market seeding studies could begin as ... In a comparison of cancer patients receiving standard oral mucositis care with ...
... NEW YORK, Sept. 11 The NY Chiropractic ... ("PCA"), the Association of New Jersey Chiropractors ("ANJC"), fourteen ... have sued as the class representatives of the putative class. ... Gross LLP and co-counsel Buttaci & Leardi, LLC, have filed ...
... heavy traffic noise had raised readings , FRIDAY, Sept. ... be bad for your blood pressure, a new study suggests. ... horns honking and brakes screeching have an increased risk of ... of Environmental Health . , A team from Lund ...
... study has found that two genes in mice were associated ... These findings give researchers new hope for developing more effective ... outcomes. This study will be presented at the Congress of ... in Dusseldorf, Germany, on Sept. 11, 2009. "Most ...
... , CUPERTINO, Calif., Sept. 11 ... reported that it has entered into a privately negotiated transaction ... of Venrock at a price of $2.25 per share, raising ... expects the financing to close on or about September 18, ...
... DUBLIN, Ohio, Sept. 11 Cardinal Health today announced the ... to purchase up to an aggregate purchase price of $1.2 billion ... tender offer is part of a previously announced plan to reduce ... of CareFusion Corp. and includes notes issued by both Cardinal Health ...
Cached Medicine News:Health News:Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United States 2Health News:Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United States 3Health News:Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United States 4Health News:Blue Cross and Blue Shield Sued by Health Care Providers for Abusive Practices 2Health News:Blue Cross and Blue Shield Sued by Health Care Providers for Abusive Practices 3Health News:Busy Roads Boost Blood Pressure 2Health News:Mayo Clinic identifies 2 genes as potential therapeutic targets for multiple sclerosis 2Health News:DURECT Announces Sale of 4,444,444 Shares of Common Stock, Raising Proceeds of $10 Million 2Health News:Cardinal Health Announces Early Tender Results of Debt Tender Offer 2Health News:Cardinal Health Announces Early Tender Results of Debt Tender Offer 3Health News:Cardinal Health Announces Early Tender Results of Debt Tender Offer 4Health News:Cardinal Health Announces Early Tender Results of Debt Tender Offer 5Health News:Cardinal Health Announces Early Tender Results of Debt Tender Offer 6
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (P3797) ... assistance. Color: colour-coded ...
... PYREX serological pipets are calibrated "to deliver" ... use in confined areas such as hoods. ... and feature negative and reverse graduations to ... measuring procedures. Packaged in plastic bags so ...
Corning 7078A multi-pack plugged capacity 5 mL...
Corning 7077B L 215 mm volume 5.0 0.1 mL...
Medicine Products: